Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Molecular and Cellular Biology|March 4, 2015
Brk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4Priyank Patel, Benedikt Asbach, Elina Shteyn, et al.Frontiers in Immunology|November 15, 2021
Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPsPatrick Neckermann, Ditte Rahbaek Boilesen, Torsten Willert, et al.International Journal of Molecular Sciences|May 11, 2024
A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike ProteinLaia Civit, Nima Moradzadeh, Anna Jonczyk, et al.BMC Immunology|March 9, 2017
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunitySascha Barabas, Theresa Spindler, Richard Kiener, et al.Cancer Immunology Research|December 19, 2022
Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome-Positive C3 Cancers in MiceDitte Rahbæk Boilesen, Patrick Neckermann, Torsten Willert, et al.Cancers|December 23, 2023
Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors' PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion AntigenJoana Daradoumis, Mikkel Dons Müller, Patrick Neckermann, et al.Frontiers in Immunology|February 21, 2024
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passagesPatrick Neckermann, Madlen Mohr, Martina Billmeier, et al.Journal of Virology|May 18, 2018
Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus VectorsRichard Kiener, Markus Fleischmann, Marian Alexander Wiegand, et al.Vaccines|September 23, 2022
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine DesignKelly A S da Costa, Joanne Marie M Del Rosario, Matteo Ferrari, et al.Viruses|August 28, 2021
Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody ResponsesAlexander Thomas Sampson, Jonathan Heeney, Diego Cantoni, et al.Pageof 4